Please scroll down for Important Safety Information

About us

Shionogi Pharma, Inc. (formerly Sciele Pharma, Inc.) is a US-based group company of Shionogi & Co., Ltd. Shionogi Pharma is based in Atlanta, Georgia and specializes in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, head lice infestations, and attention deficit/hyperactivity disorder (ADHD).

Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s Research and Development currently targets three therapeutic areas: Infectious Diseases, Pain, and Metabolic Syndrome. The Company has provided such innovative medicines as Crestor and Doripenem, which have been successfully delivered to millions of patients. In addition, Shionogi is engaged in new research areas such as allergy and cancer. Contributing to the health of patients around the world through development in these therapeutic areas is Shionogi’s primary goal. For more details, please visit www.shionogi.co.jp.

Contact information

Medical inquiries or concerns should be directed to the Shionogi Pharma, Inc. Medical Information and Drug Safety Department:

(800) 849-9707 Ext. 1454

For more information about Shionogi Pharma, Inc.
visit us at www.shionogipharma.com.

Metafolin^® is a registered trademark
of Merck KGaA, Germany.
The images contained herein are
trademarks of Shionogi Pharma, Inc.